Does Alaska Medicaid cover GLP-1s for weight loss?

Alaska Medicaid covers Wegovy and Zepbound for heart risk, MASH or sleep apnea, not for weight control

Not for weight loss alone
By Iacob Pastina, Independent Researcher & Publisher
Reviewed & updated · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

If you are an adult and weight loss is your only reason, Alaska Medicaid does not cover a GLP-1.

If one of the uses below applies to you, your prescriber can ask Alaska Medicaid to cover that drug. Read the rule and its criteria.

  • Nofor adult weight loss alone
  • Sep 18, 2026when the program last revised the rules we checked
  • $69/molowest cash price in Alaska, at Embody

Which drugs Alaska Medicaid covers, and for what:

Wegovy
Heart risk, as injection or tablets, or MASH, as the injection only
Zepbound
Sleep apnea

We checked 4 official documents on October 15, 2026. This is information, not medical advice or a benefit decision.

What does a GLP-1 cost without insurance in Alaska?

15 programs that serve Alaska publish a complete monthly price, from $69 at Embody to $297 at Direct Meds GLP-1.

Programs that serve Alaska, lowest monthly price first

Some programs are affiliate partners, and we may earn a commission if you join through our link. Payment never moves a row. How we rank

8 more programs serve Alaska without one complete monthly price: Breeze Meds, Collective, MangoRx, Maximus, Nu Image Medical, Oak Longevity, Ro and Sesame Care. Compare their terms in the price index.

We left out 13 programs whose service-area list has a caveat for Alaska or is incomplete, so confirm your address at intake.

A program that serves Alaska still decides whether to prescribe, and it does not take Medicaid. Most sell compounded semaglutide or tirzepatide, which is not FDA-approved. Check a compounded provider before you pay.

  • Lowest in Alaska$69/moAt Embody, the lowest complete monthly price among programs that serve Alaska.
  • National median$149/moThe median advertised recurring price across 11 compounded programs we track, a national benchmark, not a measured Alaska average.
  • National range$69 to $299The lowest and highest advertised recurring prices in that group.

What does Alaska Medicaid cover for GLP-1s?

Here is our summary of the Alaska Medicaid rules we checked, with their criteria and limits.

Alaska Medicaid covers Wegovy only to lower heart risk or treat MASH and Zepbound only for sleep apnea, not GLP-1 medicines for weight control, under the state's semaglutide and tirzepatide clinical criteria updated September 18, 2026. Alaska Medicaid can approve Wegovy injection or tablets if you have a BMI of 25 or more and a documented past heart attack, stroke, chronic ischemic heart disease, peripheral artery disease or atherosclerosis. It can also approve Wegovy injection, not the tablet, if you have MASH, a fatty liver disease, with F2 or F3 fibrosis. It approves Zepbound only if a sleep study confirms moderate to severe obstructive sleep apnea and you have a BMI of 30 or more. A first approval lasts up to 3 months, and a renewal up to 12 months. Alaska Medicaid does not list Saxenda or Foundayo on its preferred drug list. Ask your prescriber to send the chart notes these criteria require; Alaska Medicaid still decides each request.

A drug on the preferred list is not covered for every use, so check the rule for yours. A weight-loss exclusion leaves diabetes and other medical requests to their own rules.

We checked Alaska Medicaid clinical criteria: semaglutide (Ozempic, Wegovy), updated September 18, 2026 on October 15, 2026.

We checked Alaska Medicaid clinical criteria: tirzepatide (Mounjaro, Zepbound), updated September 18, 2026 on October 15, 2026.

We checked Alaska Department of Health prior authorization medication list on October 15, 2026.

We checked Alaska Medicaid preferred drug list, effective June 1, 2026 on October 15, 2026.

What should you ask Alaska Medicaid before you pay?

Call your Medicaid plan, Medicare drug plan or private insurer with these questions, and keep the reference number for each call.

Before you pay cash, confirm:

  • Whether your plan covers your exact drug, form and dose for your diagnosis and age.
  • Whether you are in fee-for-service or a managed-care plan, and who handles your prior authorization.
  • Which records your prescriber must send with the request.
  • Which pharmacy can fill it, and your drug copay apart from any visit, lab or membership fees.
  • Whether paying cash affects your benefits.
  • If the plan says no, the reason in writing, how to ask for a review and the deadline on the notice.

An “insurance accepted” badge does not tell you your benefit, so ask your plan how its review works.

What paperwork does prior authorization need?

Your prescriber sends Alaska Medicaid a request with the records that show you meet the rule for your drug and diagnosis, and Alaska Medicaid decides.

What Alaska Medicaid's own criteria ask for, from the documents we read:

  • For the Wegovy heart-risk route, a documented past heart attack, stroke, chronic ischemic heart disease, peripheral artery disease or atherosclerosis, with a BMI of 25 or more.
  • For Zepbound, a sleep study that confirms moderate to severe obstructive sleep apnea, with a BMI of 30 or more.
  • The chart notes the criteria require; a first approval lasts up to 3 months and a renewal up to 12 months.

What your prescriber usually sends:

  • The condition the request relies on, as Alaska Medicaid names it: Wegovy for heart risk, as injection or tablets, or MASH, as the injection only; Zepbound for sleep apnea.
  • Your BMI, with the height and weight it comes from and the date your prescriber measured them.
  • Chart notes that document the condition, such as a sleep study for sleep apnea or the liver scarring stage for MASH, where the rule asks for them.
  • The exact drug, form and dose your prescriber requests, and whether you have diabetes, because some routes exclude it.
  • What you have tried already: diet and activity changes, and any earlier medicine the rule asks about.
  • For a renewal, your weight, refill and treatment records since the first approval.

Your prescriber works from these Alaska Medicaid documents:

Your prescriber's office files the request; you cannot file it yourself. If Alaska Medicaid says no, ask for the reason in writing, because the notice tells you how to ask for a review and by when.

How does Medicare cover GLP-1s in Alaska?

Medicare's GLP-1 Bridge follows federal rules in every state, so Alaska Medicaid's policy does not decide your Medicare benefit.

GLP-1 Bridge
If your weight-management prescription qualifies and Humana, CMS's central processor, approves it, your drug copay is $50 a month. That copay does not count toward your Part D out-of-pocket spending.
Regular Part D
Ask your drug plan whether it covers your exact medicine for your diagnosis. A plan denial does not by itself make you eligible for the Bridge. Our Medicare GLP-1 coverage guide goes drug by drug.

We checked CMS's Bridge guidance for Part D plans on September 26, 2026.

Who can help with coverage in Alaska?

Two free official services can help you, and we earn no commission from either.

Medicaid
If a managed-care plan runs your drug benefit, call the member-services number on your card for its criteria and a written decision. Alaska Medicaid
Medicare counseling
Your State Health Insurance Assistance Program (SHIP) explains a plan or notice for free. It does not approve a prescription. Alaska SHIP counseling

Questions about GLP-1 access in Alaska

Does Alaska Medicaid cover GLP-1 medication for weight loss?

Alaska Medicaid covers Wegovy only to lower heart risk or treat MASH and Zepbound only for sleep apnea, not GLP-1 medicines for weight control, under the state's semaglutide and tirzepatide clinical criteria updated September 18, 2026.

Alaska Medicaid can approve Wegovy injection or tablets if you have a BMI of 25 or more and a documented past heart attack, stroke, chronic ischemic heart disease, peripheral artery disease or atherosclerosis. It can also approve Wegovy injection, not the tablet, if you have MASH, a fatty liver disease, with F2 or F3 fibrosis. It approves Zepbound only if a sleep study confirms moderate to severe obstructive sleep apnea and you have a BMI of 30 or more. A first approval lasts up to 3 months, and a renewal up to 12 months. Alaska Medicaid does not list Saxenda or Foundayo on its preferred drug list. Ask your prescriber to send the chart notes these criteria require; Alaska Medicaid still decides each request. Before you pay, confirm your exact drug, your diagnosis, any age rules and your plan's authorization steps.

Is Medicare GLP-1 coverage different in Alaska?

Yes.

Medicare's GLP-1 Bridge follows federal eligibility rules in every state, not Alaska Medicaid's policy. Your ordinary Part D coverage depends on your prescription and your drug plan, and the Bridge runs its own eligibility and authorization review.

Can I get GLP-1 medication delivered in Alaska?

Yes, from 23 online programs that publish a service area including Alaska.

At intake, confirm your address, the exact medication and any pharmacy limits, because a state listing does not guarantee you a prescription or a delivery date.

How much does GLP-1 treatment cost in Alaska?

Among programs that serve Alaska, the lowest complete monthly price we found is $69 at Embody.

Across the 11 compounded programs we track nationally, the median advertised recurring price is $149/mo, from $69 to $299. That national figure is not a measured Alaska average, insurance copay or quote for your dose.

Featured Partners

Affiliate partners we feature. We may earn a commission.

Embody

from $69/mo·Compounded

Gala

Current program options·Brand & Compounded

Check the medication, commitment and total price for your selected plan.

Bodybuilding Health+

$179/mo month-to-month·Compounded

Affiliate links, we earn a commission at no extra cost to you. These are featured partners, prioritized by our affiliate economics, not an editorial "best" ranking. Published scores have different evidence limits and do not establish better care. See the program comparison and scoring limitations.